2-pentylaniline | 53334-33-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-pentylaniline
• 英文别名: 2-n-pentylaniline
• CAS: 53334-33-1
• 化学式: C₁₁H₁₇N
• 分子量: 163.263
• InChiKey: JVYROXPHJXUAIA-UHFFFAOYSA-N

物化性质

• 沸点：
  266.7±9.0 °C(Predicted)
• 密度：
  0.937±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-pentylaniline 在 盐酸 、 sodium nitrite 作用下， 生成 N-nitroso-N-pentyl-aniline
  参考文献：
  名称：

  Radcliffe; Grindley, Journal of the Society of Dyers and Colourists, vol. 40, p. 292

  摘要：

  DOI：
• 作为产物：
  描述：

  1-nitro-2-(pent-1-en-1-yl)benzene 在 palladium on activated charcoal 氢气 作用下， 以 乙醇 为溶剂， 反应 2.0h， 生成 2-pentylaniline
  参考文献：
  名称：

  Structural Development of Liver X Receptor (LXR) Antagonists Derived from Thalidomide-Related Glucosidase Inhibitors

  摘要：

  继我们之前发现源自沙利度胺相关葡萄糖苷酶抑制剂的 2′-取代苯基邻苯二甲酰亚胺具有 LXR 拮抗活性之后，通过结构-活性研究和进一步的结构开发，我们开发出了 5-氯-N-2′-正戊基苯基-1,3-二硫代邻苯二甲酰亚胺（5CPPSS-50），其对 LXRα 和 LXRβ 的 IC50 值分别约为 10 和 13 μM。

  DOI：

  10.1248/cpb.55.1750

文献信息

• HALOGENATED DIARYLAMINE COMPOUND AND SYNTHESIS METHOD THEREOF
  申请人：OSAKA Harue

  公开号：US20110071317A1

  公开（公告）日：2011-03-24

  An object is to provide a new halogenated diarylamine compound serving as a source material for synthesis of a variety of diarylamine compounds and triarylamine compounds and a synthesis method of the new halogenated diarylamine compound. A halogenated diarylamine compound represented by the following general formula (G1) and a synthesis method thereof are provided. Note that a variety of diarylamine compounds and triarylamine compounds can be synthesized using the halogenated diarylamine compound represented by the following general formula (G1).

  提供一种新的卤代二芳胺化合物，作为合成各种二芳胺化合物和三芳胺化合物的原料，并提供一种新的卤代二芳胺化合物的合成方法。提供了由下述一般式（G1）表示的卤代二芳胺化合物及其合成方法。请注意，可以使用由下述一般式（G1）表示的卤代二芳胺化合物合成各种二芳胺化合物和三芳胺化合物。
• [EN] AMIDE DERIVATIVES AS SIRTUIN MODULATORS<br/>[FR] DÉRIVÉS D'AMIDE COMME MODULATEURS DE SIRTUINES
  申请人：SIRTRIS PHARMACEUTICALS INC

  公开号：WO2009058348A1

  公开（公告）日：2009-05-07

  Provided herein are novel sirtuin-modulating compounds represented by Structural Formula (I) and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benfit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin- modulating compound in combination with another therapeutic agent.

  提供的是由结构公式（I）表示的新的sirtuin调节化合物及其用途。sirtuin调节化合物可用于延长细胞寿命，以及治疗和/或预防多种疾病和紊乱，例如与衰老或压力、糖尿病、肥胖、神经退行性疾病、心血管疾病、凝血障碍、炎症、癌症和/或潮红相关的疾病或紊乱，以及将从增加线粒体活性中受益的疾病或紊乱。还提供了包含sirtuin调节化合物与另一种治疗剂的组合的药物组合物。
• QUINOLINIUM ION DERIVATIVES, PROCESS FOR THE PRODUCTION OF THE DERIVATIVES, PRODUCTS MADE BY USING THE SAME, AND REDUCTION AND OXIDATION METHODS WITH THE DERIVATIVES
  申请人：Fukuzumi Shunichi

  公开号：US20100004454A1

  公开（公告）日：2010-01-07

  An electron donor-acceptor dyad is provided that can provide a charge-separated state with longevity and not only high oxidizing power but also high reducing power. A compound of the present invention is a quinolinium ion derivative represented by the following formula (I), a stereoisomer or tautomer thereof, or a salt thereof: where R 1 is a hydrogen atom or an alkyl group, and Ar 1 to Ar 3 each are a hydrogen atom or an electron-donating group. The compound of the present invention has the above-mentioned structure and therefore can provide a charge-separated state with longevity and not only high oxidizing power but also high reducing power and can be used for various products such as photocatalysts, photosensitizers, dyes, oxidants, reductants, dye-sensitized solar cells, and organic EL devices.

  提供了一个电子给体-受体二聚体，可以提供一个具有长寿命的电荷分离状态，不仅具有高氧化能力，而且具有高还原能力。本发明的化合物是由以下式(I)表示的喹啉离子衍生物，其立体异构体或互变异构体，或其盐： 其中R1是氢原子或烷基，Ar1至Ar3分别是氢原子或电子给体基团。本发明的化合物具有上述结构，因此可以提供一个具有长寿命的电荷分离状态，不仅具有高氧化能力，而且具有高还原能力，并且可用于各种产品，如光催化剂、光敏剂、染料、氧化剂、还原剂、染料敏化太阳能电池和有机EL器件。
• PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND
  申请人：Ohkubo Kei

  公开号：US20120171111A1

  公开（公告）日：2012-07-05

  The present invention provides a process for producing an oxidation reaction product of an aromatic compound, having excellent environmental load reduction performance, cost reduction performance, etc. Provided is a process for producing an oxidation reaction product of a raw material aromatic compound by reacting the raw material aromatic compound with an oxidizing agent. The process further uses an electron donor-acceptor linked molecule. The process includes the step of: reacting the electron donor-acceptor linked molecule in an electron-transfer state, the oxidizing agent, and the raw material aromatic compound, thereby generating an oxidation reaction product resulting from oxidation of the raw material aromatic compound.

  本发明提供了一种生产芳香化合物氧化反应产物的工艺，具有优异的环境负荷减少性能、成本降低性能等。提供了一种通过将原料芳香化合物与氧化剂反应来生产原料芳香化合物的氧化反应产物的工艺。该工艺进一步使用了电子给体-受体连接分子。该工艺包括以下步骤：在电子转移状态下将电子给体-受体连接分子、氧化剂和原料芳香化合物反应，从而生成由原料芳香化合物氧化产生的氧化反应产物。
• [EN] SMALL MOLECULE INDUCERS OF REACTIVE OXYGEN SPECIES AND INHIBITORS OF MITOCHONDRIAL ACTIVITY<br/>[FR] INDUCTEURS DE PETITES MOLÉCULES DE DÉRIVES RÉACTIFS DE L'OXYGÈNE ET INHIBITEURS DE L'ACTIVITÉ MITOCHONDRIALE
  申请人：UNIV MICHIGAN REGENTS

  公开号：WO2017155991A1

  公开（公告）日：2017-09-14

  This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a quinazolinedione structure which function as reactive oxygen species (ROS) inducers and inhibitors of mitochondrial activity within cancer cells (e.g., pancreatic cancer cells), and their use as therapeutics for the treatment of cancer (e.g., pancreatic cancer) and other diseases.

  这项发明属于药物化学领域。具体来说，该发明涉及一类具有喹唑啉二酮结构的小分子，其作为活性氧（ROS）诱导剂和对癌细胞（例如胰腺癌细胞）内线粒体活性的抑制剂，并将它们用作治疗癌症（例如胰腺癌）和其他疾病的药物。